BioCryst Pharmaceuticals
BCRX
#4942
Rank
NZ$3.48 B
Marketcap
NZ$13.54
Share price
-2.10%
Change (1 day)
9.35%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2026 (TTM): NZ-$2.34

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$2.45. In 2025 the company made an earnings per share (EPS) of NZ$2.27 an increase over its 2024 EPS that were of NZ-$0.78.

EPS history for BioCryst Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.34-203.17%
2025NZ$2.27-390.7%
2024NZ-$0.78-63.56%
2023NZ-$2.15-11.28%
2022NZ-$2.4229.13%
2021NZ-$1.87-4.63%
2020NZ-$1.9610.2%
2019NZ-$1.780%
2018NZ-$1.7825.64%
2017NZ-$1.424%
2016NZ-$1.3627.12%
2015NZ-$1.07-13.24%
2014NZ-$1.2423.64%
2013NZ-$1.00-30.38%
2012NZ-$1.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ-$5.64 129.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.23-313.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ-$4.78 94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ-$0.36-85.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ-$2.76 12.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.91 222.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ-$0.80-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$5.78 135.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$9.16 273.33%๐Ÿ‡บ๐Ÿ‡ธ USA